Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at dovitinib to treat advanced transitional cell cancer that has spread

Overview

Cancer types:

Bladder cancer, Kidney cancer, Transitional cell cancer

Status:

Results

Phase:

Phase 2

Details

This trial was for people with transitional cell cancer that had spread into the surrounding tissue (locally advanced) or to another part of the body.

Recruitment start: 2 June 2010

Recruitment end: 25 October 2011

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr John Chester

Supported by

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Novartis

Last reviewed: 07 Jun 2016

CRUK internal database number: 6631

Help and support